Imagine that there will come a time in the future where scientists and researchers will eventually discover the cure for HIV. So far there have been some promising results, and now it seems that Johnson & Johnson researchers are ready to test what they think could potentially be a vaccine for the disease.
The new vaccine is a tetravalent mosaic and is composed of four components. These components have been designed to help increase the body's immune system to fight back the different strands of the virus. During the animal testing phase, it was found that two thirds of the tests were successful, which means that while it is not a 100% cure or prevention, it works to some extent.
These trials will begin with humans and cover 3,800 men by the end of the year. It will also cover a variety of regions including Europe, South America and North America, which includes the United States. The study participants are expected to receive six vaccine vaccines in four sessions, with the results of the trial expected in 2023.
It remains to be seen if this could potentially lead to a cure / prevention for the disease, but it seems to be a good step in the right direction.
Filed in cnet. More information on health and science. Source: